Related Experiment Videos
A comparative study between animals and monoclonal anti-digitoxin antibodies
International Journal of Nuclear Medicine and Biology
|January 1, 1984
Summary
Rabbit-produced anti-digitoxin antibodies show better overall performance than monoclonal antibodies, though both are useful for quantitative assays. Monoclonal antibodies offer large quantities for treating digitalis overdose.
Area of Science:
- Immunology
- Pharmacology
Background:
- Digitalis overdose is a life-threatening condition requiring effective treatment.
- Anti-digitoxin antibodies are crucial for neutralizing digoxin and digitoxin toxicity.
Purpose of the Study:
- To produce and characterize anti-digitoxin antibodies using both polyclonal (rabbit) and monoclonal techniques.
- To compare the performance of polyclonal and monoclonal anti-digitoxin antibodies for potential therapeutic and diagnostic applications.
Main Methods:
- Production of polyclonal antibodies by immunizing rabbits with a digitoxin-protein conjugate.
- Generation of monoclonal antibodies using hybridoma technology with the same conjugate.
- Characterization of antibody performance, including titers, inhibition curves, affinities, and kinetic constants (dissociation and association rate-constants).
Main Results:
- Both polyclonal and monoclonal antibodies were successfully produced.
- Polyclonal antibodies exhibited superior performance in most criteria, except for specificity.
- Monoclonal antibodies demonstrated lower sensitivity but offered the advantage of large-scale, consistent production.
- Both antibody types are suitable for quantitative assays.
Conclusions:
- Polyclonal anti-digitoxin antibodies derived from rabbit immune serum provide robust parameters for assays.
- Monoclonal anti-digitoxin antibodies, while less sensitive, are advantageous for mass production and potential therapeutic use in digitalis overdose cases.